Subsequent CCK8 assay (Fig. 5B) and EdU assay (Fig. 5C) revealed a marked enhancement in the proliferative activity of AML-12 and THLE-2 cells following METTL3 knockdown. The gene discussed is METTL3; the disease is acute myeloid leukemia.